LPCN-2203

N/A

Report date: 2024/11/27 16:46:45
NME

Base Information

Drug NameLPCN-2203
Drug Alias NameLPCN-2203
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor modulators
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsEssential Tremor
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLipocine Inc
China Registration ClassN/A

Develop Information

Active CompaniesLipocine Inc
Inactive CompaniesN/A
Active IndicationsEssential Tremor
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A